Condition: Chronic Pain · Sponsor: Navy Medical Center San Diego
The goal of this clinical trial is to evaluate if a supplement called palmitoylethanolamide (PEA) is effective in reducing the pain in patients with chronic inflammatory pain conditions. The main question the trial aims to answer is if PEA works better at treating a patients pain and improving their function better than a placebo. Participants will be divided into two equal groups and asked to take either PEA or a placebo for 8 weeks.
This description comes directly from the study's public registry record.
Brian McLean Pain Physician, MD · 619-532-8495 · brian.c.mclean.mil@health.mil
IRB Administrator · 619-532-9083 · kristina.m.umali.civ@health.mil
Always discuss trial participation with your own doctor first.
| Naval Medical Center San Diego | San Diego, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06273462